Skip to main content
. Author manuscript; available in PMC: 2009 Jan 20.
Published in final edited form as: Nat Genet. 2007 Dec 9;40(1):43–50. doi: 10.1038/ng.2007.30

Figure 6.

Figure 6

Expression of Myc-repressed miRNAs disadvantages lymphoma cell growth in vivo. (a) Myc3 or 38B9 lymphoma cells were infected with a retrovirus expressing a miRNA and GFP. The percentage of GFP-positive cells was measured before and after tumor formation. (b) Cells expressing select miRNAs are eliminated from tumors. Data are mean ± s.d. from three independent trials. At least 30% of cells were positive for GFP before injection into recipient mice.